Nina Cosdon

The VRBPAC committee unanimously voted in favor of the Janssen (Johnson & Johnson) COVID-19 vaccine for use under EUA as a booster dose in individuals 18 years and older at least 2 months after a single dose primary vaccination.

In a recent study, taniborbactam restored in vitro activity of cefepime against Enterobacterales.

While receiving a booster of one’s original COVID-19 shot leads to an immune boost, this was heightened among individuals who received a different booster than their primary vaccine.

The FDA suggested that Johnson & Johnson had not conducted an appropriately thorough test to prove its vaccine requires a six-month booster.

People who inject drugs in rural areas had a less accurate understanding of HIV PrEP, largely due to stigma surrounding sexual orientation and drug use.

A recent study by the CDC found that HIV PrEP awareness and referrals are lower among Hispanic persons than non-Hispanic white persons.

In the recent TACKLE phase 3 trial, AZD7442 significantly reduced the risk of developing severe COVID-19 or death, even among high-risk populations.

If the FDA approves maribavir, it will be the first and only treatment for adults with CMV as a result of a hematopoietic stem cell transplant or solid organ transplant.

A global study of C. difficile isolates worldwide found a very high prevalence of the bacteria on shoe soles.

A recent study measured premature deaths among people with HIV by sex, race, and HIV risk factor.

Qatar has the highest mRNA vaccine coverage in the world, but their vaccinated population is experiencing significant waning in vaccine efficacy, leading to breakthrough infections.

Malaria has afflicted humanity for thousands of years, and the parasite is especially deadly for children and babies. The WHO has recommended the first malaria vaccine be deployed across sub-Saharan Africa.

This investigational therapy could be the first implantable form of PrEP.

AstraZeneca’s long-acting antibody, AZD7442, would act as a supplement to vaccination and could provide up to a year of protection against symptomatic COVID-19.

People who inject drugs are at high-risk for HIV infection, but very few are interested in PrEP prescriptions.

This study confirmed reports from the CDC and Israel Ministry of Health that found the Pfizer-BioNTech vaccine waned after 6 months.

A study found similar rates of acute respiratory illness-related visits across race/ethnicity when all healthcare settings were combined, but ARI visits differed for race/ethnicity groups across ambulatory, emergency, and hospital settings.

Learn more about new test for diagnosing early Lyme disease in a Q&A with Adaptive Biotechnologies.

Self-testing for HIV is fast and easy, and test kits can be completed at a health department with the help of staff or at home and dropped off later.

The COVID-19 pandemic led people to take hygiene and sanitation more seriously, causing a decrease in C difficile infections.

After an initial hospitalization for COVID-19, some patients may have specific risk factors that increase their likelihood of readmittance.

Massachusetts General Hospital investigated how international travel contributes to the contraction and carriage of antimicrobial resistance (AMR).

The Arkansas Health Department’s research showed that, as with the rest of the population, Delta is severely infectious for children.

A survey found most healthcare professionals would clear an asymptomatic patient with a positive PCR test if the patient met other criteria.

A study found disproportionately higher COVID-19 cases in Black and Hispanic people with HIV across the US.

Orange County, CA nursing homes that partook in either universal decolonization or prevention training had significantly fewer staff and resident COVID-19 cases than nursing homes that did not.

Investigators saw vastly higher rates of hospitalization and mortality for rural populations over urban even after adjusting the results for various factors.

Rates of Sexually Transmitted Infections (STIs) and engagement in HIV pre-exposure prophylaxis during the COVID-19 pandemic were previously unknown, but one IDWeek study examined these data trends over the past few years.

Pre-exposure prophylaxis (PrEP) is safe and effective for preventing HIV when used correctly, but this information is not as well-known as it should be, new study finds.

Mortality rates of children with HIV may be underreported due to lack of patient follow-up and the usage of routine program data.